BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease Life Science Investing
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development Life Science Investing
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting Pharmaceutical Investing
Boston Scientific announces conference call discussing first quarter 2026 results Life Science Investing
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right Life Science Investing
Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204 Life Science Investing
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations Life Science Investing
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026 Life Science Investing
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases Life Science Investing
Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform Life Science Investing
